Summary

Surgical Robots Market Analysis

The surgical robots market size was valued at USD 8.24 billion in 2025 and is estimated to grow from USD 9.05 billion in 2026 to reach USD 13.90 billion by 2031, at a CAGR of 8.96% during the forecast period (2026-2031). Robust capital spending by consolidated hospital systems, demographic pressure from aging populations in Europe and Japan, and rapid progress in artificial-intelligence-enabled vision and force feedback are widening the procedure mix to include complex cardiovascular and neurosurgical cases. Reimbursement improvements from the Centers for Medicare and Medicaid Services and China’s National Reimbursement Drug List are shortening payback periods on new installations, even as recent device recalls and a shortage of fellowship-trained surgeons in tier-2 cities temper near-term momentum. Portable and cart-based platforms that can shuttle between operating rooms or ambulatory surgical centers are attracting budget-sensitive buyers, while onshore component manufacturing in the United States is mitigating tariff risk and qualifying equipment for Buy America provisions. Competitive intensity remains elevated as incumbents refresh installed bases and challengers position modular systems to undercut acquisition costs and expand the surgical robots market into underserved specialties.

Global Surgical Robots Market Trends and Insights



Aging-Driven Orthopaedic and Urologic Procedure Surge

Europe’s share of residents aged 65 and above is on track to hit 30% by 2050, while Japan already reports a 29% cohort, sustaining high volumes of knee and hip arthroplasty plus robotic prostatectomy. Orthopaedic robots such as Stryker’s Mako and Zimmer Biomet’s Rosa Knee are reducing revision rates, a metric that feeds bundled-payment incentives, Urologic demand also benefits as older male populations face rising benign prostatic hyperplasia and prostate cancer incidence, supporting uptake of da Vinci and Hugo systems. Japan’s 2024 reimbursement expansion for additional gastrointestinal and urologic indications accelerated hospital procurement. These demographic forces underpin long-run growth in the surgical robot’s market well past 2031.

AI-Enabled Vision and Haptic Feedback Expanding Soft-Tissue Indications

Artificial-intelligence vision now classifies tissue and tracks instruments in real time, lowering cognitive load during delicate dissections. Intuitive Surgical’s da Vinci 5 integrates force feedback that cuts peak suture tension by 43%, improving anastomosis quality. Johnson and Johnson’s pending OTTAVA system predicts instrument collisions and optimizes port placement, addressing ergonomic barriers. Haptic guidance is especially valuable in cardiovascular robotics; Medtronic’s Hugo earned clearance for urologic use in 2025 and is pursuing cardiac applications. Collectively, these enhancements widen the addressable pool beyond high-volume general surgery, extending the surgical robot’s market into complex, premium-reimbursement cases.

Long Capital Pay-Back in Middle East and Africa Hospitals

Many Middle Eastern and African facilities log fewer than 200 robotic procedures a year, stretching payback beyond seven years and deterring boards seeking sub-five-year returns. Shared-service models rotate robots across hospital groups, but scheduling complexity suppresses utilization. Sparse reimbursement schedules further cloud margins, while outbound medical tourism siphons complex cases. Isolated bright spots such as tertiary centers in Johannesburg and Dubai prove viability yet represent a small slice of regional demand. Until procedure counts or equipment pricing shifts, low-volume headwinds will cap regional uptake within the global surgical robot’s market.

Other drivers and restraints analyzed in the detailed report include:

CMS and NRDL Reimbursement Expansion Improving Hospital ROIHospital-System Capital Pooling Favouring Multi-Specialty PlatformsDevice-Recall Incidents Denting Surgeon Confidence

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Services revenue is projected to rise at 9.53% through 2031, overtaking system growth as hospitals lock in multiyear maintenance, software, and training contracts that protect uptime. Recurring instruments and accessory sales exceeded USD 4 billion for Intuitive Surgical in 2025, highlighting a pivot toward annuity-like flows tied to utilization rather than capital cycles. High switching costs deter hospitals from platform changes, anchoring manufacturer margins and making services the steadiest pillar of the surgical robot’s market.

Surgical systems still generated 57.59% of 2025 component revenue, buoyed by upgrade cycles in North America and first-wave placements in Asia-Pacific. Intuitive shipped 532 systems in 4Q 2025 alone, with 303 da Vinci 5 units meeting pent-up demand for advanced vision and force feedback. Domestic vendors in China and India are broadening access at lower price points, yet the shift toward services signals a maturing installed base that will redefine how the surgical robots market size grows across the decade.

Neurosurgery is on pace for a 9.32% CAGR to 2031 as spine and cranial robots demonstrate sub-millimeter accuracy that reduces revision rates and nerve injury. Medtronic’s Stealth AXiS, cleared in February 2026, integrates imaging with navigation, while Zimmer Biomet’s 2025 acquisition of Monogram Orthopaedics underscores strategic intent to enter autonomous bone preparation. These entrants diversify the surgical robot’s market beyond orthopaedic anchors.

Orthopaedic procedures retained 36.41% of 2025 volume thanks to knee and hip arthroplasty throughput, yet saturation in high-income regions is slowing incremental growth. Cardiovascular and thoracic applications remain nascent, but recent da Vinci 5 cardiac approvals hint at future upside. This specialty diversification supports steady expansion of the surgical robot’s market share across multiple disciplines.

The Surgical Robots Market Report is Segmented by Component (Surgical Systems, Instruments and Accessories, and Training, and Services), Area of Surgery (Gynecological, Urological, Orthopedic, Neurosurgery, Cardiovascular, General and Laparoscopic, Thoracic, and Morespecialties), End-User (Hospitals, and More), Product (Non-Portable Systems, and More), and Geography. Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

North America leads global revenue thanks to early da Vinci adoption, established reimbursement, and 18% 2025 procedure growth. CMS outpatient eligibility is widening access, while tariff-driven on-shore manufacturing secures supply continuity. Canada’s provincial coverage expansion and Mexico’s private-sector investments further enlarge the regional surgical robot’s market.

Europe benefits from entrenched orthopaedic and urologic penetration in Germany, the United Kingdom, France, and Italy. The European Union Medical Device Regulation raises entry barriers, favouring incumbents with robust clinical data. Rising adoption in Spain and Portugal follows Intuitive Surgical’s 2025 distribution consolidation, while local Russian initiatives aim to offset import constraints.

Asia-Pacific is the fastest-growing geography, propelled by China’s NRDL coverage in major provinces and Japan’s reimbursement additions for prostatectomy and gastrectomy. Domestic vendors such as MicroPort undercut prices, scaling access and swelling regional surgical robots market size. India is emerging via private hospital chains expanding into tier-2 cities, and South Korea sustains double-digit growth through government innovation incentives.

The Middle East and Africa remain restrained by low procedure volume and uncertain reimbursement, though tertiary centers in Dubai, Riyadh, and Johannesburg show viable economics. South America sees gradual rollout in Brazil and Argentina via public-private financing, yet currency volatility tempers capital commitments. As Asia-Pacific accelerates, North America’s share moderates, but the broader surgical robots market continues to expand as price points fall and regulatory clarity improves across regions.

List of Companies Covered in this Report:

Intuitive Surgical Inc. Medtronic plc Stryker Corporation Johnson & Johnson (Ethicon / Auris Health) Zimmer Biomet Holdings Inc. Smith & Nephew plc CMR Surgical Ltd. Asensus Surgical Inc. THINK Surgical Inc. Renishaw plc Accuray Incorporated Titan Medical Inc. Vicarious Surgical Inc. MicroPort MedBot Beijing TINAVI Medical Technologies Meere Company Apollo Endosurgery Inc. Verb Surgical JV EchoNous Inc. Hocoma AG

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

ページTOPに戻る

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.4 Executive Summary

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Aging-driven orthopedic and urologic procedure surge in Europe and Japan
4.2.2 AI-enabled vision and haptics expanding complex soft-tissue indications
4.2.3 CMS and NRDL reimbursement expansion improving hospital ROI
4.2.4 Hospital-system capital pooling favoring multi-specialty robotic platforms
4.2.5 ASC shift fueling demand for compact, portable robots
4.2.6 Under-reported: 2025-onwards U.S. tariff pressure accelerating on-shore component manufacturing
4.3 Market Restraints
4.3.1 Long capital pay-back in low-volume Middle East and Africa hospitals
4.3.2 Device-recall incidents (2022-24) denting surgeon confidence
4.3.3 Shortage of fellowship-trained robotic surgeons in Tier-2 cities
4.3.4 Under-reported: Cyber-security liability premiums raising total cost of ownership
4.4 Industry Value-Chain Analysis
4.5 Impact of Macroeconomic Factors on the Market
4.6 Regulatory Landscape
4.7 Technological Outlook
4.8 Porter's Five Forces Analysis
4.8.1 Threat of New Entrants
4.8.2 Bargaining Power of Suppliers
4.8.3 Bargaining Power of Buyers
4.8.4 Threat of Substitutes
4.8.5 Intensity of Competitive Rivalry
4.9 Investment and Funding Landscape

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)
5.1 By Component
5.1.1 Surgical Systems
5.1.2 Instruments And Accessories
5.1.3 Training
5.1.4 Services (Maintenance)
5.2 By Area of Surgery
5.2.1 Gynecological
5.2.2 Urological
5.2.3 Orthopedic
5.2.4 Neurosurgery
5.2.5 Cardiovascular
5.2.6 General and Laparoscopic
5.2.7 Thoracic
5.2.8 Other Specialties
5.3 By End-user
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Specialty Clinics
5.4 By Product
5.4.1 Non-portable Systems
5.4.2 Portable / Cart-based Systems
5.4.3 Mobility Platforms
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 South America
5.5.2.1 Brazil
5.5.2.2 Argentina
5.5.2.3 Rest of South America
5.5.3 Europe
5.5.3.1 United Kingdom
5.5.3.2 Germany
5.5.3.3 France
5.5.3.4 Italy
5.5.3.5 Russia
5.5.3.6 Rest of Europe
5.5.4 Asia-Pacific
5.5.4.1 China
5.5.4.2 Japan
5.5.4.3 India
5.5.4.4 South Korea
5.5.4.5 Rest of Asia-Pacific
5.5.5 Middle East
5.5.5.1 Israel
5.5.5.2 Saudi Arabia
5.5.5.3 United Arab Emirates
5.5.5.4 Turkey
5.5.5.5 Rest of Middle East
5.5.6 Africa
5.5.6.1 South Africa
5.5.6.2 Egypt
5.5.6.3 Rest of Africa

6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
6.4.1 Intuitive Surgical Inc.
6.4.2 Medtronic plc
6.4.3 Stryker Corporation
6.4.4 Johnson & Johnson (Ethicon / Auris Health)
6.4.5 Zimmer Biomet Holdings Inc.
6.4.6 Smith & Nephew plc
6.4.7 CMR Surgical Ltd.
6.4.8 Asensus Surgical Inc.
6.4.9 THINK Surgical Inc.
6.4.10 Renishaw plc
6.4.11 Accuray Incorporated
6.4.12 Titan Medical Inc.
6.4.13 Vicarious Surgical Inc.
6.4.14 MicroPort MedBot
6.4.15 Beijing TINAVI Medical Technologies
6.4.16 Meere Company
6.4.17 Apollo Endosurgery Inc.
6.4.18 Verb Surgical JV
6.4.19 EchoNous Inc.
6.4.20 Hocoma AG

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
7.1 White-space and Unmet-need Assessment